MPC Therapeutics announces completion of its CHF 1.5M seed-funding round to improve CAR-T cancer therapies.
stephanie.dhont2023-01-17T15:31:53+01:00MPC Therapeutics supported by MATWIN in 2022 and awarded by MATWIN [...]
MPC Therapeutics supported by MATWIN in 2022 and awarded by MATWIN [...]
Smart Immune supported by MATWIN in 2022 and awarded “ Best Therapeutic Innovation” [...]
Download here the latest MATWIN newsletter :
Introduce us SMARTIMMUNE in a few words Smart Immune, a [...]
MATWIN is a partner of the 10th International Cancer Cluster Showcase, international [...]
[...]
Download the press release here
Download the press release here
Download the press release here
The Fondation ARC Léopold Griffuel Award is one of the [...]